|
|
|
|
Non-Small Cell Lung Cancer
Eye On Stocks For Tues., March 14, 2006 14 Mar 2006
Forbes ...second best-selling product behind Zyprexa, is currently approved to treat breast cancer, pancreatic cancer and certain types of non-small cell lung cancer. ...
OSI Pharma's Cancer Drug Data May Boost Stock 14 Mar 2006
Forbes ...from this study will nevertheless serve as a catalyst for the stock and may increase the duration of therapy in second-line NSCLC [non-small cell lung cancer ...
Panel says no to new Gemzar use 14 Mar 2006
United Press International ...design or conduct.". Gemzar is currently approved to treat non-small cell lung cancer, metastatic breast cancer and pancreatic cancer.
IDM and Medison Pharma Sign an Exclusive Marketing Agreement for ... 14 Mar 2006
PR Newswire (press release), Three products are in Phase II clinical trials in bladder cancer, melanoma and non-small cell lung cancer, and one is in Phase I in colorectal cancer. ...
CRP may detect lung cancer risk in smokers Mar 12, 2006
Independent Online, ...be helpful in the design of future chemoprevention and early detection studies by identifying high-risk subjects for non-small-cell lung cancer," the authors ...
About Non-Small Cell Lung Cancer (NSCLC) Feb 16, 2006
WebWire (press release), Lung cancer is the leading cause of cancer death for both men and women – claiming more lives than colon, breast, and prostate cancers combined. ...
Cell Therapeutics, Inc. CEO Talks About Lung Cancer Treatments for ... Mar 9, 2006
PharmaLive.com (press release), ...treatment. We need to better understand the biological role of estrogen in the development of non-small cell lung cancer (NSCLC). ...
CRP may help predict lung cancer risk in smokers Mar 11, 2006
Trade Arabia, ...be helpful in the design of future chemoprevention and early detection studies by identifying high-risk subjects for non-small-cell lung cancer,' the authors ...
Genta Incorporated Announces Fourth Quarter and Year End 2005 ... Mar 10, 2006
PR Newswire (press release), ...trials of Genasense in combination with various types of chemotherapy have completed enrollment, including studies in non small cell lung cancer, small cell ...
Millennium and Johnson & Johnson Pharmaceutical Research & ... Mar 6, 2006
PR Newswire (press release), ...of a three-arm, randomized, Phase II study of VELCADE and pemetrexed in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who ...
Dana Reeve, a Nonsmoker, Dies of Lung Cancer at 44 Mar 7, 2006
MedPage Today, ...and colleagues. The non-smokers in Dr. Pao's study had adenocarcinoma non-small cell lung cancer (NSCLC). Patients with mutations ...
Cell Therapeutics, Inc. (CTI) Reports 2005 Fourth Quarter and Year ... Mar 9, 2006
MSN Money Reported prospective analysis of phase II trial (PGT202) demonstrating estrogen-linked survival benefit for women with non-small cell lung cancer on XYOTAX ...
Who Are Lung Cancer's Victims? Mar 7, 2006
CBS News ...than 45. The most common type of lung cancer is non-small cell lung cancer, according to the National Cancer Institute. Lung cancer ...
Inflammatory Biomarker Helps Identify Progressive Precancerous ... Mar 6, 2006
Science Daily (press release) ...reported each year. Most of these are non-small cell lung cancer and the overall prognosis once diagnosed is dismal. The only reasonable ...
Dana Reeves Dies After Battling Lung Cancer; For Most Patients ... Mar 7, 2006
U.S. Newswire (press release), Fortunately, surgeons at GW Hospital use video-assisted thoracic surgery (VATS) that allows diagnosis and treatment of non-small cell lung cancer early in its ...
Drugs added to cancer guidelines Mar 9, 2006
Monsters and Critics.com, ...'A few years ago, the idea that we could have a two-year survival for patients with Stage 4 non-small cell lung cancer was not in the picture,' Ettinger said ...
Computed Tomography Screening for Lung Cancer Detects Early ... Mar 1, 2006
Cancer Consultants (press release), ...with lung cancer. There were 436 with non-small cell lung cancer (NSCLC) and 28 small cell lung cancer (SCLC). They observed that ...
Researchers Block Cancer-Promoting Signals in Most Common Form of ... Mar 7, 2006
eMaxHealth.com, ...used a therapeutic gold compound to block cancer-promoting signals between key proteins involved in the development of non-small cell lung cancer (NSCLC), the ...
Allos Therapeutics Appoints Paul L. Berns as President and CEO Mar 10, 2006
PR Newswire (press release), DHFR inhibitor) currently under investigation as both a single agent and in combination therapy regimens in patients with non-small cell lung cancer and Non ...
COMUNICADO: Lilly Launches Phase III Trial of Targeted Cancer ... Mar 9, 2006
Europa Press, ...is also being studied in multiple other tumor types, including non-Hodgkin's lymphoma, colorectal cancer, non-small cell lung cancer, pancreatic cancer, and ...
My Friend Zola Levitt diagnosed with lung cancer please pray. Feb 26, 2006
annointed.net, Feb. 20, a biopsy was performed and Zola was diagnosed with stage 4 Metastasic squamous cell Non-Small Cell Lung Cancer (NSCLC). ...
Biomira Inc. announces year-end results Mar 9, 2006
Yahoo! News (press release) ...in October of compelling survival data from our phase 2b study, which showed that patients with Stage IIIb locoregional non-small cell lung cancer who received ...
What Are The Stages Of Lung Cancer? Feb 17, 2006
DailyIndia.com, ...all, the stage numbering system differs slightly depending on whether the lung cancer has been diagnosed as small cell lung cancer or non-small cell lung cancer ...
Bayer, Onyx on phase 3 lung cancer trial Feb 16, 2006
United Press International EMERYVILLE, Calif., Feb. 16 (UPI) -- Bayer and Onyx said Thursday they have begun a phase 3 study of Nexavar for non-small cell lung cancer (NSCLC). ...
New Erbitux approval to head off cancer Mar 6, 2006
In-PharmaTechnologist.com, ...combination with platinum-based chemotherapy, as well as a second-line treatment of advanced colon cancer and first-line treatment of non-small cell lung cancer ...
What Is Lung Cancer And Who Can Get It? Feb 17, 2006
DailyIndia.com, ...after diagnosis. Small cell lung cancer and non-small cell lung cancer are the two types of lung cancer that can develop. Eighty ...
Blood Protein Could Signal Lung Disease Risk Mar 1, 2006
Forbes ...this study may eventually help in the design of chemopreventive and early-detection studies, by identifying people at high risk for non-small cell lung cancer. ...
Bouquets: A community venture Mar 11, 2006
Escanaba Daily Press, We cannot begin to express our gratitude and what it has meant to our family. Eric has been diagnosed with stage four, non-small cell lung cancer. ...
OXiGENE Reports Fourth Quarter and Fiscal Year 2005 Operational ... Mar 1, 2006
Genetic Engineering News, ...into later stage and randomized clinical trials in indications that now comprise our core program in oncology -- Non Small Cell Lung Cancer and Platinum ...
Tumor Size Linked to Metastasis in Early Lung Cancer Feb 15, 2006
CNN IA and IB system -- either above or below 30 mm in diameter -- proved far too gross for an accurate estimation of non-small-cell lung cancer's nodal spread ...
Point Therapeutics initiates phase III lung cancer trial Feb 10, 2006
Pharmaceutical Business Review ...the first patient in the company's second phase III clinical trial, which will evaluate its anticancer drug talabostat in metastatic non-small cell lung cancer ...
Antibodies are the first wave of IGF-1R antagonists for cancer ... Mar 6, 2006
TransWorldNews (press release), Pfizer is leading the field with the fully human IgG2 antibody CP-751,871 under investigation for multiple myeloma and advanced non-small cell lung cancer. ...
Eli Lilly Launches Phase III Study Of Enzastaurin For Brain Tumor ... Mar 9, 2006
Trading Markets, ...enzastaurin has been studied in multiple other tumor types, including non-Hodgkin's lymphoma, colorectal cancer, non-small cell lung cancer, pancreatic cancer ...
Novelos Therapeutics Files SPA with FDA for Phase 3 Development in ... Mar 8, 2006
Genetic Engineering News, Protocol Assessment (SPA) with the Food and Drug Administration (FDA) for a single pivotal Phase 3 trial in advanced non-small cell lung cancer, for its lead ...
Onyx, Bayer start Phase III trial of lung cancer drug Feb 16, 2006
San Francisco Business Times, ...and Bayer Phamaceuticals Corp. said Thursday they have begun a late-stage trial of the drug Nexavar in patients with non-small cell lung cancer. ...
Gemcitabine Adds Benefit to Lung Cancer Chemotherapy Feb 23, 2006
Cancerpage.com, YORK FEB 22, 2006 (Reuters Health) - Addition of gemcitabine to a standard chemotherapy regime in selected patients with non-small-cell lung cancer can improve ...
Superior vena cava replacement for lung cancer using a ... Feb 14, 2006
The Journal of Thoracic and Cardiovascular Surgery Superior vena cava resection with prosthetic replacement for non-small cell lung cancer. long term results of a multicentric study. ...
Genasense(R) New Drug Application Accepted for Review by FDA Mar 1, 2006
Yahoo! News (press release) ...and non-randomized clinical trials, including chronic lymphocytic leukemia, acute myeloid leukemia, malignant melanoma, non-small cell lung cancer, small cell ...
CT Screening Identifies Curable Lung Cancers Feb 13, 2006
Medscape (subscription) Among non-small cell lung cancer cases, the proportion of cases with no metastases ranged from 91% of patients in whom the tumor was 15 mm or smaller, to 55 ...
Active Biotech to Present at the Cowen & Company 26th Annual ... Mar 6, 2006
WebWire (press release), ...properties for the treatment of multiple sclerosis, as well as ANYARA for use in cancer immunotherapy with the primary indication non-small cell lung cancer. ...
Lilly starts phase 3 trial of enzastaurin Mar 9, 2006
United Press International ...is studying whether enzastaurin could be useful in treating other cancers, including non-Hodgkin's lymphoma, colorectal cancer and non-small cell lung cancer.
OSI Pharmaceuticals Announces Year End 2005 Financial Results Mar 7, 2006
Genetic Engineering News, OSI to obtain FDA approval and the only EGFR inhibitor to have demonstrated the ability to improve survival in both non-small cell lung cancer and pancreatic ...
Medinet, University of Tokyo, Shin-Yokohama Medical Clinic Jointly ... Mar 2, 2006
Japan Corporate News (press release), ...studies of activated self gamma-delta T cell therapy, in which they aim to verify the safety and effectiveness of the therapy against non-small cell lung cancer ...
UPDATE 1-Bayer, Onyx begin lung cancer test of Nexavar Feb 16, 2006
Reuters ...(ONXX.O: Quote, Profile, Research) on Thursday said they had begun a late-stage trial of their drug Nexavar among patients with non-small-cell lung cancer. ...
Point Therapeutics to Host Fourth Quarter and Fiscal Year 2005 ... Mar 7, 2006
Genetic Engineering News, ...adjuvants. Point is currently studying its lead product candidate, talabostat, in two Phase 3 trials in non-small cell lung cancer. ...
Growing Evidence Of Sex-based Differences In Lung Cancer ... Feb 12, 2006
Medical News Today (press release), 2005. Non-small cell lung cancer is the most common form of lung cancer, accounting for approximately 87 percent of cases. While ...
Lung Cancer Drug Pipeline Update Lists All 243 Drugs for Lung ... Feb 16, 2006
Genetic Engineering News, ...every year in the US. Over 800,000 people worldwide dies of non-small cell lung cancer (NSCLC) each year. More people die of lung ...
ImClone’s Erbitux Receives FDA Label In Head And Neck Cancer Mar 2, 2006
BioWorld Online (subscription), Tarceva gained approval in November 2004 to treat patients with locally advanced or metastatic non-small-cell lung cancer who have failed at least one prior ...
Bayer and partner launch Phase 3 trial for lung cancer treatment Feb 17, 2006
Boston Mass High Tech, Nexavar (sorafenib) tablets administered in combination with the chemotherapeutic agents carboplatin and paclitaxel in patients with non-small cell lung cancer ...
Spectrum Pharmaceuticals announces Presentation of New Satraplatin ... Feb 27, 2006
PR Newswire (press release), ...advantageous. A Phase 1/2 study evaluating this combination in patients with non-small cell lung cancer has been initiated. Several ...
AEterna Zentaris Reports 2005 Fourth Quarter and Full-Year ... Mar 1, 2006
MSN Money ...and initiation of Phase 1/2 trial for prostate cancer in the US; and - Perifosine: Initiation of a Phase 2 trial in non-small cell lung cancer in Europe ...
FDA to review Genta drug in leukemia indication Mar 2, 2006
Pharmaceutical Business Review ...also studying Genasense in multiple, late-stage clinical trials, including acute myeloid leukemia, malignant melanoma, non-small cell lung cancer, small cell ...
Smaller Lung Cancers Less Likely to Have Spread Feb 16, 2006
Cancer Consultants (press release), For both non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), patients with smaller tumors were more likely to be free of metastases: ...
Survival Benefit Linked to Estrogen in Women Treated With XYOTAX ... Feb 15, 2006
PR Newswire (press release), ...updated results of a phase II study of XYOTAX in combination with carboplatin among 35 women and 39 men with advanced non-small cell lung cancer (NSCLC). ...
Erbitux gets US green light for head and neck cancer Mar 2, 2006
Pharma Times (subscription), ...treatment of advanced colon cancer, the first-line treatment of recurrent and head and neck cancer and the first-line treatment of non-small cell lung cancer.
Genta leukemia drug accepted for review Mar 1, 2006
United Press International ...said it is also testing the drug for use in treating other cancers including acute myeloid leukemia, malignant melanoma, non-small cell lung cancer, small cell ...
Mother Nature's pharmacy Mar 4, 2006
Jerusalem Post, ...of her work, a drug named Taxol was developed, and over one million people with breast, ovarian, head & neck and non-small-cell lung cancer have benefited. ...
(PRN) Recent FDA Action Validates ADVEXIN(R) Registration Strategy ... Mar 3, 2006
Houston Chronicle, ...preclinical data showing enhanced therapeutic effects of combined ADVEXIN(R) and Erbitux(R) therapies in an animal model of human non-small cell lung cancer. ...
PDL's Potent Pick-Me-Up Feb 27, 2006
BusinessWeek STARS) is successful in expanding its use to include additional indications, including the treatment of metastatic breast cancer and non-small cell lung cancer ...
Alfacell Achieves Full Patient Enrollment Milestone for the ... Feb 27, 2006
PR Newswire (press release), In addition to the Phase IIIb UMM registration trial, the Company is conducting an ONCONASE Phase I / II trial in Non-Small Cell Lung Cancer (NSCLC). ...
Region briefs Mar 9, 2006
Florence Morning News, Thursday. Proceeds from the dinner will help defray the medical costs of Graham’s battle with type III non-small cell lung cancer. ...
GPC says satraplatin well tolerated in Phase I Feb 27, 2006
Reuters ...prostate cancer, and had received Taxotere, a chemotherapy treatment for some types of cancer, including breast, prostate and non-small cell lung cancer. ...
Cancer drug more effective in women than men Feb 17, 2006
Pharmaceutical Business Review ...results of a phase II study of Xyotax in combination with carboplatin among 35 women and 39 men with advanced non-small cell lung cancer (NSCLC) confirmed the ...
Toll-like receptor therapies compete to reduce side effects Mar 6, 2006
Nature.com (subscription), 3 clinical trials. The first, PF-3512676, is being developed by Coley Pharmaceuticals for non-small cell lung cancer. The second ...
CXCR4 Target Plays Central Role In Cancer Progression In More Than ... Feb 18, 2006
Medical News Today (press release), ...risks associated with the planned Phase II clinical trial of DCVax(R)-Brain and the planned Phase I clinical trial for non-small cell lung cancer and head and ...
Point Therapeutics' Diabetes Program Presented at Keystone ... Mar 6, 2006
Genetic Engineering News, As our phase 3 talabostat trials for non-small cell lung cancer (NSCLC) and multiple phase 2 trials for other oncology indications advance in the clinic, we ...
Kosan Reports 2005 Fourth Quarter and Year End Results Mar 2, 2006
Yahoo! News (press release) ...including a modest reduction in clinical expenses due to the discontinuation of KOS-862 Phase II clinical trials in non-small cell lung cancer and prostate ...
Astragalus-Based Chinese Herbs May Boost Chemotherapy's Punch Feb 15, 2006
Cancerpage.com, Astragalus-based Chinese herbs appear to augment the effectiveness of platinum-based chemotherapy for advanced non-small-cell lung cancer, according to a meta ...
Tapestry Reports Fourth Quarter and Full Year 2005 Results Feb 23, 2006
MSN Money Taxane sensitive cell lines in which TPI 287 shows activity include cell lines derived from breast cancer, uterine cancer and non-small cell lung cancer. ...
Nektar Announces Financial Results for the Year and Fourth Quarter ... Feb 28, 2006
Genetic Engineering News, Chiron's Tobramycin inhalation powder for lung infections in cystic fibrosis patients in Phase III; UCB's CDP791 for non small cell lung cancer in Phase II ...
(PRN) - 485 Courts in Session With Tyler's INCODE Municipal Court ... Mar 6, 2006
Bolsamania.com, ...& Johnson Pharmaceutical Research & Development Initiate Randomized Phase II Trial of VELCADE(R) (Bortezomib) for Injection in Non-Small Cell Lung Cancer ... ...
Brain Cancer Patients Living Longer and Doing Better After ... Feb 22, 2006
PR Newswire (press release), ...or DCVax(R)-Brain will demonstrate safety and efficacy, risks associated with the planned Phase I clinical trial for non-small cell lung cancer and head and ...
ImClone Systems Announces Complete Enrollment of Several Studies ... Feb 16, 2006
Genetic Engineering News, The third study, FLEX, also sponsored by Merck KGaA, explores the first-line use of ERBITUX in advanced non-small cell lung cancer. ...
Point Therapeutics Announces Collaboration with the National ... Feb 14, 2006
Genetic Engineering News, Talabostat is currently being studied in two Phase 3 studies in adult patients who have advanced non-small cell lung cancer as well as several phase 2 studies ...
Point Therapeutics collaborates with National Cancer Institute Feb 15, 2006
Pharmaceutical Business Review Talabostat is currently being studied in two phase III studies in adult patients who have advanced non-small cell lung cancer as well as several phase II ...
Enrollment done in Erbitux cancer trials Feb 16, 2006
United Press International ...in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck and the second in patients with advanced non-small cell lung cancer. ...
Stage IB NSCLC Patients With Poor Lung Function Benefit from Intra ... Feb 16, 2006
Cancer Consultants (press release), ...the University of Pittsburgh have reported that brachytherapy can prevent local recurrences in patients with stage IB non-small cell lung cancer (NSCLC) who ...
Telik Announces Initiation of Phase 1-2A Clinical Study of ... Feb 22, 2006
International News Service, TELCYTA(R) (TLK286), a cancer cell-activated product candidate that is in three Phase 3 registration trials in advanced ovarian and non-small cell lung cancer. ...
The Abraxane Story: A Nanoparticle Platform Delivers Improved ... Feb 12, 2006
Nanotechwire.com, Hawkins also presented data from subsequent clinical trials demonstrating that Abraxane is also effective at treating non-small cell lung cancer and metastatic ...
Millennium And Johnson & Johnson Reveals Phase II Study Of VELCADE ... Mar 6, 2006
Trading Markets, ...of a three-arm, randomized, Phase II study of VELCADE and pemetrexed in patients with locally advanced or metastatic non-small cell lung cancer who have failed ...
AEterna Zentaris Reports 2005 Fourth Quarter and Full-Year ... Mar 1, 2006
Black Enterprise, Keryx, while completing patient recruitment for the Company's current combination with radiotherapy Phase 2 trial in non-small cell lung cancer; - AN-152 ...
Cancer, AIDS drugs may get cheaper after Budget Feb 22, 2006
Economic Times, Aventis Pharma, which sells its breast, prostate and non-small cell lung cancer drug Taxotere (chemical name Irinotecan) for Rs 8,250 for a 20-mg vial and ...
AEterna Zentaris: Update on US NCI sponsored Phase III trial with ... Feb 17, 2006
PharmaLive.com (press release), States National Cancer Institute (NCI) has decided to interrupt patient recruitment for the ongoing Phase III trial in non-small cell lung cancer (NSCLC) with ...
AEterna Drug Study Enrollment Halted Feb 17, 2006
Houston Chronicle, The late-stage trial is studying the effect of Neovastat in patients with non-small cell lung cancer, the most common type of lung cancer. ...
Novelos Therapeutics Submits ''Dirty Bomb'' Treatment Proposal to ... Feb 22, 2006
PharmaLive.com (press release), A US-based Phase 1/2 clinical study of NOV-002, in combination with chemotherapy, in non-small cell lung cancer (NSCLC) demonstrated positive results. ...
Bayer, Onyx launch Phase III trial of Nexavar to treat lung drug ... Feb 16, 2006
Forbes AG said it and its partner Onyx Pharmaceuticals Inc are launching a phase III trial of their drug Nexavar to treat non-small cell lung cancer in combination ...
Recruitment halted for Aeterna's Neovastat trial Feb 17, 2006
Reuters Canada, 380 patients. Neovastat is designed to treat non-small cell lung cancer in combination with radiotherapy and chemotherapy. Shares ...
Genzyme launches test to monitor Gleevec resistance Feb 13, 2006
News-Medical.net, Gleevec. Genzyme Genetics offers two tests that identify non-small cell lung cancer (NSCLC) patients likely to respond to therapies. ...
SCIREX Appoints Dr. Susan Shelby Executive Director, Clinical ... Feb 15, 2006
Pharmaceutical Processing, Her clinical research experience in the areas of oncology and hematology includes cutaneous T-cell lymphoma, advanced non-small cell lung cancer, renal cancer ...
(PRN) - It's All Shiny And New ... [+] Feb 16, 2006
Bolsamania.com, ...[+]. (PRN) - Bayer and Onyx Initiate Phase III Non-Small Cell Lung Cancer Trial Studying Nexavar (sorafenib) Tablets in Combination With Two Chemotherapeutic ...
Efaproxiral May Improve Survival in Patients with Brain Metastases ... Feb 15, 2006
Cancer Consultants (press release), ...of efaproxiral plus oxygen in glioblastoma multiforme showed promising results.[2] A phase II study in patients with non-small cell lung cancer (NSCLC) with ...
OncoGenex Appoints New CFO and Board Member Feb 14, 2006
PharmaLive.com (press release), ...currently has several programs in mid and early stage clinical development for various cancers including prostate cancer, non-small cell lung cancer and breast ...
Bayer's share price falls on 4Q results Mar 6, 2006
Pharma Times (subscription), He reiterated the view that two of Bayer's new drugs, Nexavar (sorafenib) for non-small cell lung cancer and the oral Factor Xa inhibitor for thrombotic ...
ImClone Systems Announces Complete Enrollment of Several Studies ... Feb 17, 2006
Financial News USA (press release), ...(NYSE: ONXX) and Bayer Phamaceuticals Corp. said Thursday they have begun a late-stage trial of the drug Nexavar in patients with non-small cell lung cancer. ...
Coley Pharmaceutical Group Reports Fourth Quarter and Full Year ... Feb 23, 2006
MSN Money ...study of CPG 7909 in combination with chemotherapy for first-line treatment of both of the major histologic subtypes of non-small cell lung cancer, or NSCLC. ...
Idera Pharmaceuticals to Participate in Focus Session at BIO CEO & ... Feb 13, 2006
Genetic Engineering News, ...targets TLR9 and is currently in a Phase 2 monotherapy trial in renal cell carcinoma, and a Phase 1/2 combination therapy trial in non-small-cell lung cancer. ...
CFO of IDM Pharma plans to step down Feb 16, 2006
TMCnet Three products are in phase II clinical trials in bladder cancer, melanoma and non-small cell lung cancer, and one is in phase I in colorectal cancer. ...
Vitamin A-Like Compound Fights Lung Cancer 25 Jan 2006
Forbes ...effects," You said. Previous research found that bexarotene extended survival in some patients with non-small cell lung cancer. The US ...
Health briefs: Alzheimer’s; lung cancer; soy 25 Jan 2006
Times Online, ...patients. An Australian study followed 2,337 patients with non-small-cell lung cancer (NSCLC) considered too advanced for treatment. ...
Chinese Herbal Medicine May Increase Effectiveness of Platinum ... 25 Jan 2006
Cancer Consultants (press release), Astragalus-based Chinese herbal medicine may increase the effectiveness of platinum-based chemotherapy regimens for advanced non-small cell lung cancer (NSCLC ...
ImClone Considering Sale; Erbitux Growth Continues 25 Jan 2006
BioWorld Online (subscription), ...this year. Other clinical trials are nearing full accrual in non-small-cell lung cancer and in metastatic head and neck cancer. The ...
Phosphagenics initiates anti-cancer compound animal trials 25 Jan 2006
BiopharmaReporter.com, Paclitaxel (Taxol), for the treatment of ovarian, breast and non-small cell lung cancer, achieved sales of over $1.5bn in 2000 prior to the introduction of ...
Vitamin A for lung cancer? Jan 21, 2006
myDNA.com, In previous studies, bexarotene showed some promise in extending survival in cancer patients with non-small cell lung cancer, the most common type of lung ...
Pleural Lavage Cytology Helps Predict Outcomes in Non-Small Cell ... Jan 12, 2006
Cancer Consultants (press release), Annals of Thoracic Surgery, pleural lavage cytology is significantly associated with survival outcomes in patients with non-small cell lung cancer and should ...
Scientists find unusual lung-cancer tumor-suppressor gene Jan 19, 2006
innovations report, ...examined the region in about 50 tumor samples from patients with head and neck squamous-cell carcinomas and with non-small-cell lung cancer, which is ...
Bexarotene shows promise in lung cancer treatment Jan 18, 2006
RxPG NEWS, It extended survival in patients with non-small cell lung cancer, the most common type of lung cancer and one that has a five-year survival rate of less than 5 ...
Small Percentage of 'Terminal' Lung Cancer Patients Inexplicably ... Jan 24, 2006
Daily News Central, ...indicate that a chance for prolonged survival and possibly even cure exists for approximately 1 percent of patients with non small-cell lung cancer who receive ...
Avax initiates lung cancer vaccine trial Jan 19, 2006
Pharmaceutical Business Review By Staff Writer. Avax Technologies is commencing enrollment in its phase I/II study in patients with non-small cell lung cancer. ...
Spectrum Issues Update on Satraplatin Jan 23, 2006
PR Newswire (press release), ...advantageous. A Phase 1/2 study evaluating this combination in patients with non-small cell lung cancer has been initiated. Several ...
AVAX Technologies Announces the Initiation of its Clinical Study ... Jan 17, 2006
PharmaLive.com (press release), ...(OTCMarket: AVXT.OB) today announces that enrollment is commencing for its Phase I/II study in patients with Non-Small Cell Lung Cancer. ...
AVAX Technologies Announces the Initiation of its Clinical Study ... Jan 17, 2006
Finanzen.net, AVAX Technologies, Inc. (OTCMarket: AVXT.OB) todayannounces that enrollment is commencing for its Phase I/II study inpatients with Non-Small Cell Lung Cancer. ...
Scientists isolate suppressor gene as potential drug target Jan 20, 2006
In-PharmaTechnologist.com, ...examined the region in about 50 tumour samples from patients with head and neck squamous-cell carcinomas and with non-small-cell lung cancer, which is ...
Vitorâ„¢ Slows Cachexia in Cancer Patients Jan 17, 2006
Cancer Consultants (press release), ...to results from a recent clinical trial, the oral agent Vitorâ„¢ slows the progression of cachexia in patients with colon cancer and non-small cell lung cancer ...
Anesthesia in plastic surgery is studied Jan 23, 2006
Science Daily (press release) ...surgery increases options (December 6, 2005) -- Los Angeles surgeons say some elderly patients with early stage, non-small cell lung cancer might benefit from ...
A blog to bare your soul Jan 21, 2006
Malaysia Star, Foo Hee Boon, who has metastasised, non-small cell lung cancer, sees his blog as a way to present a positive response to his ailment. ...
Longtime Councilwoman Butler of Port Royal dies of lung cancer Jan 11, 2006
Hilton Head Island Packet, Port Royal Councilwoman Yvonne Butler died Tuesday morning in her home, less than three weeks after being diagnosed with non-small cell lung cancer, her family ...
Value of Low-Dose CT For Lung Cancer Screening Still Uncertain Jan 11, 2006
Cancerpage.com, ...at high risk for lung cancer, low-dose chest computed tomography (LDCCT) is useful in detecting early peripheral non-small cell lung cancer, researchers report ...
Cytokinetics Raising $33M For Clinic, Corporate Uses Jan 18, 2006
BioWorld Online (subscription), ...is in eight ongoing Phase II trials, three of those conducted by the company's partner, London-based GSK in non-small-cell lung cancer, ovarian cancer and ...
TESMILIFENE in Combination With TAXOTERE(R) (docetaxel) on Trial ... Jan 10, 2006
PR Newswire (press release), ...ii) for locally advanced or metastatic breast cancer after anthracycline-based therapy, (iii) as a first-line therapy for non-small cell lung cancer, (iv) as a ...
Lilly's Gemzar For Ovarian Cancer To Receive Oncologics Cmte. ... Jan 19, 2006
FDA Advisory Committee Gemzar in combination with cisplatin is currently approved for treatment of inoperable, metastatic non-small cell lung cancer; in combination with paclitaxel ...
Pfizer Fourth-Quarter and Full-Year 2005 Financial Results Reflect ... Jan 19, 2006
PR Newswire (press release), In the fourth quarter of 2005, Pfizer began two Phase 3 trials for non-small-cell lung cancer using a novel anti-cancer agent PF-3512676 (formerly CpG 7909 ...
Human Genome Sciences Reports on Progress Toward Commercialization ... Jan 10, 2006
PR Newswire (press release), During 2005, HGS completed and reported the results of Phase 2 trials of HGS-ETR1 as monotherapy in advanced non-small cell lung cancer, advanced colorectal ...
Hormone Replacement Therapy Associated with Decreased Survival in ... Jan 9, 2006
Cancer Consultants (press release),
| |
